Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer

Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression

(2014) Patrizia Sanità et al.   BMC CANCER

A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer

(2014) Nelma Pértega-Gomes et al.   BMC CANCER

Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?

(2014) Nelma Pértega-Gomes et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Monocarboxylate Transporter 4 Facilitates Cell Proliferation and Migration and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma Patients

(2014) Jiang Zhu et al.   PLoS One

Targeting glucose metabolism in patients with cancer

(2013) Shannon E. Elf et al.   CANCER

The SLC16 gene family – Structure, role and regulation in health and disease

(2013) Andrew P. Halestrap   MOLECULAR ASPECTS OF MEDICINE

Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition

(2012) Anne R. Diers et al.   BIOCHEMICAL JOURNAL

Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer

(2012) Isabelle Dufau et al.   BMC CANCER

Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target

(2012) Marco Gerlinger et al.   JOURNAL OF PATHOLOGY

Influence of the MCT1-T1470A polymorphism (rs1049434) on blood lactate accumulation during different circuit weight trainings in men and women

(2012) Rocío Cupeiro et al.   JOURNAL OF SCIENCE AND MEDICINE IN SPORT

Inhibition of Monocarboxylate Transporter 2 Induces Senescence-Associated Mitochondrial Dysfunction and Suppresses Progression of Colorectal Malignancies In Vivo

(2012) I. Lee et al.   MOLECULAR CANCER THERAPEUTICS

Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets

(2012) Vera Miranda-Gonçalves et al.   NEURO-ONCOLOGY

Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer

(2011) Nelma Pértega-Gomes et al.   BMC CANCER

Regulation of Monocarboxylate Transporter MCT1 Expression by p53 Mediates Inward and Outward Lactate Fluxes in Tumors

(2011) R. Boidot et al.   CANCER RESEARCH

Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF- B/IL-8 Pathway that Drives Tumor Angiogenesis

(2011) F. Vegran et al.   CANCER RESEARCH

Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells

(2011) Hiroto Izumi et al.   CANCER SCIENCE

Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma

(2010) Céline Pinheiro et al.   HISTOPATHOLOGY

Genetic Variations in the MCT1 (SLC16A1) Gene in the Chinese Population of Singapore

(2009) Choo Bee Lean et al.   Drug Metabolism and Pharmacokinetics

MCT1 genetic polymorphism influence in high intensity circuit training: A pilot study

(2009) Rocío Cupeiro et al.   JOURNAL OF SCIENCE AND MEDICINE IN SPORT

Molecular Basis of Colorectal Cancer

(2009) Sanford D. Markowitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis

(2008) Juan Su et al.   CANCER LETTERS

Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas

(2008) Céline Pinheiro et al.   VIRCHOWS ARCHIV